Literature DB >> 26718213

MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.

Yang Liu1, Honglin Zhou1, Lan Ma2, Youfang Hou1, Jing Pan1, Chunyi Sun1, Yingying Yang1, Jie Zhang3.   

Abstract

Ovarian cancer is one of the most common human malignancies in women. MiR-214 and semaphorin 4D (sema 4D) were found to be abhorrently expressed and involved in the progress of several kinds of malignant cancers. This study is aimed to investigate the cellular role of miR-214 and demonstrate that miR-214 negatively regulated sema 4D in ovarian cancer cells. The data showed that miR-214 expression was consistently lower in ovarian cancer tissues and cells than those in the normal controls. Over-expression of miR-214 in ovarian cancer SKOV-3 cells inhibited cell proliferation and induced apoptosis. It was suggested that miR-214 functioned as the tumor suppressor in ovarian cancer. Bioinformatic analysis indicated that miR-214 possibly regulated sema 4D by binding the sema 4D messenger RNA (mRNA) 3'-untranslated region (UTR). Sema 4D mRNA and protein levels were up-regulated in ovarian cancer tissues and SKOV-3 cells. Up-regulation of miR-214 in SKOV-3 cell line suppressed the sema 4D expression in both protein and nucleic acid levels. While, down-regulation of miR-214 in SKOV-3 cells would increase sema 4D protein and nucleic acid expression levels. The effects of miR-214 up- and down-regulation on luciferase activities of wild-type (WT) sema 4D 3'-UTR were completely removed upon introduction of mutation in 3'-UTR of WT sema 4D. Therefore, the data also demonstrated that sema 4D was the direct target of miR-214 and was negatively regulated by miR-214 in ovarian cancer cells.

Entities:  

Keywords:  Expression; MiR-214; Negative regulation; Ovarian cancer; Semaphorin 4D

Mesh:

Substances:

Year:  2015        PMID: 26718213     DOI: 10.1007/s13277-015-4708-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

Review 1.  Plexins: axon guidance and signal transduction.

Authors:  M Negishi; I Oinuma; H Katoh
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

Review 2.  The many faces of semaphorins: from development to pathology.

Authors:  L Roth; E Koncina; S Satkauskas; G Crémel; D Aunis; D Bagnard
Journal:  Cell Mol Life Sci       Date:  2009-02       Impact factor: 9.261

3.  Effects and mechanism of miR-214 on hepatocellular carcinoma.

Authors:  Li-Li Zhang; Yan-Jun Guo; Chun-Na Zhao; Jian-Yun Gao
Journal:  Asian Pac J Trop Med       Date:  2015-05       Impact factor: 1.226

4.  MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.

Authors:  Rui-Qing Peng; Hai-Ying Wan; Hai-Fang Li; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

5.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

6.  miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.

Authors:  Zhengyu Xu; Tao Wang
Journal:  Biochem Biophys Res Commun       Date:  2014-05-04       Impact factor: 3.575

Review 7.  The semaphorins: versatile regulators of tumour progression and tumour angiogenesis.

Authors:  Gera Neufeld; Ofra Kessler
Journal:  Nat Rev Cancer       Date:  2008-06-26       Impact factor: 60.716

8.  miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Authors:  Min Deng; Qiurong Ye; Zailong Qin; Ying Zheng; Wei He; Hailin Tang; Yanhong Zhou; Wei Xiong; Ming Zhou; Xiaoling Li; Qun Yan; Jian Ma; Guiyuan Li
Journal:  Tumour Biol       Date:  2013-03-13

9.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Authors:  Hua Yang; William Kong; Lili He; Jian-Jun Zhao; Joshua D O'Donnell; Jiawang Wang; Robert M Wenham; Domenico Coppola; Patricia A Kruk; Santo V Nicosia; Jin Q Cheng
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

10.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

  10 in total
  19 in total

1.  Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.

Authors:  Jingli Sun; Shaofeng Gao; Cuihua Lu
Journal:  Mol Cell Biochem       Date:  2019-06-03       Impact factor: 3.396

2.  Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.

Authors:  Patrice Cagle; Nikia Smith; Timothy O Adekoya; Yahui Li; Susy Kim; Leslimar Rios-Colon; Gagan Deep; Suryakant Niture; Christopher Albanese; Simeng Suy; Sean P Collins; Deepak Kumar
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

3.  Insufficient CD100 shedding contributes to suppression of CD8+ T-cell activity in non-small cell lung cancer.

Authors:  Hong-Min Wang; Xiao-Hong Zhang; Li-Qun Ye; Kai Zhang; Ning-Ning Yang; Shen Geng; Jing Chen; Shun-Xin Zhao; Kang-Li Yang; Fei-Fei Fan
Journal:  Immunology       Date:  2020-04-07       Impact factor: 7.397

4.  miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.

Authors:  Hang Tian; Lei Hou; Yu-Mei Xiong; Jun-Xiang Huang; Wen-Hua Zhang; Yong-Ying Pan; Xing-Rong Song
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

5.  circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.

Authors:  Shifan Zhou; Zhizhong Guo; Chaofeng Zhou; Yu Zhang; Sai Wang
Journal:  Cancer Cell Int       Date:  2021-05-06       Impact factor: 5.722

6.  MicroRNA miR-214 Inhibits Snakehead Vesiculovirus Replication by Promoting IFN-α Expression via Targeting Host Adenosine 5'-Monophosphate-Activated Protein Kinase.

Authors:  Chi Zhang; Shuangshuang Feng; Wenting Zhang; Nan Chen; Abeer M Hegazy; Wenjie Chen; Xueqin Liu; Lijuan Zhao; Jun Li; Li Lin; Jiagang Tu
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 7.  Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer.

Authors:  Jianghui Meng
Journal:  Oncotarget       Date:  2017-06-20

8.  Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.

Authors:  Jinrong Liao; Jinghui Lin; Dong Lin; Changyan Zou; Jessica Kurata; Renjang Lin; Zhiyong He; Ying Su
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

9.  Regulation of semaphorin 4D expression and cell proliferation of ovarian cancer by ERalpha and ERbeta.

Authors:  Y Liu; Y Hou; L Ma; C Sun; J Pan; Y Yang; H Zhou; J Zhang
Journal:  Braz J Med Biol Res       Date:  2017-02-20       Impact factor: 2.590

10.  Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer.

Authors:  J L Hu; G Y He; X L Lan; Z C Zeng; J Guan; Y Ding; X L Qian; W T Liao; Y Q Ding; L Liang
Journal:  Oncogenesis       Date:  2018-02-20       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.